ESPERION THERAPEUTICS INC NEW

ESPR appears to have completed a textbook ABC correction. Look out for a upside target of recent highs of $48.21 and more. SL: Recent lows at $30.95

$ESPR hits major resistance with unusual put volume 2017-04-21 40.00 P BOT @ 3.20 #options #option #ichimoku #stocks #stock #stocktweets

I trade charts not fundamentals, this thing had ugly earnings and a Trump rumor of approval of cholesterol-lowering treatment drug make this run 300% in past 2 months. 30.5s is the big resistance, RSI peaking 80 3 times, this thing will correct soon. short 30.5, stop 31.5, don't marry it, it was breaking higher 2 times already, this thing was holding 9 EMA really ...

Potential long. Reported solid phase 1 and phase 2 results for its drug Bempedoic Acid. Amgen is soon releasing results from a similar drug; if results are promising, $ESPR could trend up. Also forming cup and handle pattern.

still bullish for a further GAP fill.

for potential GAP fill.

This company has shifted from Micro cap to a Small Cap, That is a big deal. Wait for it to see the profit taking (distribution). Then add some puts and ride it lower. Limit your risk with options. Do not short this for a swing trade. Use Options.

Ready.